BGI Genomics Co Ltd (300676) — Cash Flow Quality Index
BGI Genomics Co Ltd (300676) has a Cash Flow Quality Index of -0.29x as of June 2025. Operating cash flow of CN¥-16.74 Million is below net income of CN¥58.47 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 300676 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BGI Genomics Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for BGI Genomics Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BGI Genomics Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for BGI Genomics Co Ltd (2012–2023)
Year-by-year earnings quality comparison for BGI Genomics Co Ltd. For live market cap and the full company financial profile, see 300676 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 4.40x | CN¥408.77 Million | CN¥92.90 Million | ▲ +2598.8% |
| 2022 | 0.16x | CN¥130.88 Million | CN¥802.77 Million | ▼ -90.4% |
| 2021 | 1.69x | CN¥2.48 Billion | CN¥1.46 Billion | ▼ -1.1% |
| 2020 | 1.71x | CN¥3.60 Billion | CN¥2.10 Billion | ▲ +111.2% |
| 2019 | 0.81x | CN¥224.25 Million | CN¥276.33 Million | ▲ +2036.4% |
| 2018 | 0.04x | CN¥14.69 Million | CN¥386.65 Million | ▼ -93.8% |
| 2017 | 0.61x | CN¥243.66 Million | CN¥398.09 Million | ▼ -13.0% |
| 2016 | 0.70x | CN¥234.07 Million | CN¥332.69 Million | ▼ -43.9% |
| 2015 | 1.25x | CN¥328.68 Million | CN¥262.10 Million | ▲ +999.0% |
| 2014 | -0.14x | CN¥-8.16 Million | CN¥58.53 Million | ▼ -165.6% |
| 2013 | 0.21x | CN¥36.70 Million | CN¥172.67 Million | ▼ -75.0% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥85.35 Million | — |